Adaptive Methods: When and How Should They be Used in Clinical Trials?

被引:0
|
作者
Porcher, Raphael [2 ]
Lecocq, Brigitte [1 ]
Vray, Muriel [3 ]
机构
[1] Novartis Pharma SAS, Lab Novartis, F-92506 Rueil Malmaison, France
[2] Univ Paris Diderot, Hop St Louis, Paris, France
[3] Inst Pasteur, Paris, France
来源
THERAPIE | 2011年 / 66卷 / 04期
关键词
interim analysis; adaptative trial; experimental design; amendement; treatment selection; CONTINUAL REASSESSMENT METHOD; HYPOTHESES SELECTION; DRUG DEVELOPMENT; 2-STAGE DESIGNS; PHASE-I; INTERIM; SURVIVAL; POWER;
D O I
10.2515/therapie/2011044
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adaptive clinical trial designs are defined as designs that use data cumulated during trial to possibly modify certain aspects without compromising the validity and integrity of the said trial. Compared to more traditional trials, in theory, adaptive designs allow the same information to be generated but in a more efficient manner. The advantages and limits of this type of design together with the weight of the constraints, in particular of a logistic nature, that their use implies, differ depending on whether the trial is exploratory or confirmatory with a view to registration. One of the key elements ensuring trial integrity is the involvement of an independent committee to determine adaptations in terms of experimental design during the study. Adaptive methods for clinical trials are appealing and may be accepted by the relevant authorities. However, the constraints that they impose must be determined well in advance.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 50 条
  • [31] Randomized clinical trials - How long should they last?
    Wellens, HJ
    CIRCULATION, 2004, 110 (02) : 107 - 108
  • [32] How should we analyse hospitalizations in clinical trials?
    Dickstein, K
    Snapinn, S
    EUROPEAN HEART JOURNAL, 2003, 24 (01) : 24 - 25
  • [33] Public Clinical Trials: which Kind of Monitoring Should be Used?
    Cornu, Catherine
    Binquet, Christine
    Thalamas, Claire
    Vigouroux, Celine
    Gaillard, Segolene
    Ginhoux, Tiphanie
    Vaz, Bernadette
    Jossan, Claire
    Felin, Alexandra
    Sailly, Annabelle
    Gueyffier, Francois
    Journot, Valerie
    Kassai, Behrouz
    THERAPIE, 2013, 68 (03): : 135 - 141
  • [34] Adaptive design methods in clinical trials - a review
    Chow, Shein-Chung
    Chang, Mark
    ORPHANET JOURNAL OF RARE DISEASES, 2008, 3 (1)
  • [35] Adaptive design methods in clinical trials – a review
    Shein-Chung Chow
    Mark Chang
    Orphanet Journal of Rare Diseases, 3
  • [36] Cognitive and behavioural assessment in clinical trials: when should they be done?
    Aldenkamp, AP
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 155 - 157
  • [37] How and when should a CO2 removal device be used?
    de Pablo, R.
    Ortiz, A. Blandino
    MEDICINA INTENSIVA, 2023, 47 (01) : 45 - 47
  • [38] WHAT IS SPERM BANKING - WHEN AND HOW IS IT (OR SHOULD IT BE) USED IN HUMANS - ANIMALS
    ROTHMANN, SA
    JOURNAL OF ANDROLOGY, 1995, : 31 - 34
  • [39] How effective is temozolomide for treating pituitary tumours and when should it be used?
    Halevy, Carmel
    Whitelaw, Benjamin C.
    PITUITARY, 2017, 20 (02) : 261 - 266
  • [40] THERAPEUTIC ACHLORHYDRIA - FOR WHAT DISEASES, WHEN AND FOR HOW LONG SHOULD IT BE USED
    KOOP, H
    ARNOLD, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (13) : 516 - 518